Stay updated on Immunotherapy Combination in Solid Cancers Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combination in Solid Cancers Clinical Trial page.

Latest updates to the Immunotherapy Combination in Solid Cancers Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.4 is now shown on the page, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study site locations have been expanded with new entries across multiple US states and international locations (CA, CO, IA, MI, NH, OH, PA, TN, NSW, VIC, AB, BC, Hyōgo, Tokyo). The page also shows a revision update (v3.3.3) and removal of the HHS Vulnerability Disclosure link.SummaryDifference1%

- Check56 days agoChange DetectedAdded a note stating that publications are automatically filled from PubMed and may not all be about the study, replacing the previous PubMed-derived description. Updated the revision tag from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page's government funding/operating status notice has been removed, leaving the study details and other content unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check84 days agoChange DetectedResults data were added to the study record with Results First Submitted on 2025-08-08 and Results First Posted on 2025-08-29, and the Outcome Measures section was expanded to include adverse events, objective response rate, duration of response, progression-free survival, and PK/PD parameters.SummaryDifference0.3%

- Check106 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference3%

Stay in the know with updates to Immunotherapy Combination in Solid Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combination in Solid Cancers Clinical Trial page.